Deliverable D1.6 Optimised list of indicators WP1

P-A-R-C HORIZON-HLTH-2021-ENVLTH-03 CONTRACT N. 101057014 This partnership has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No 101057014. P-A-R-C HORIZON-HLTH-2021-ENVLTH-03 CONTRACT N. 101057014 This partnership has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No 101057014. 3 WP1 – Partnership Management and Coordination T 1.3 – Impact evaluation and Monitoring of the performance indicators of the Partnership VITO / DOMG, Brussels, Belgium INSA National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal DOMG, INSA, ANSES, VITO Maja MAMPAEY, DOMG, [email protected] Henriqueta LOURO, INSA, [email protected]-saude.pt Karen Van Campenhout (dOMG), Maria João Silva (INSA), Adrienne Pittman (ANSES), Liese Gilles (VITO) MB members 30/04/2023 22/11/2023 4 5 6 Technical reference _____________________________________________________________________________ 3 Document history _______________________________________________________________________________ 4 Abstract __________________________________________________________________________________________ 5 Keywords ________________________________________________________________________________________ 5 Authors and Acknowledgments ________________________________________________________________ 7 List of abbreviations ____________________________________________________________________________ 7 1. Introduction ________________________________________________________________________________ 8 1.1 Background _______________________________________________________________________________ 8 1.2 Objectives _________________________________________________________________________________ 9 1.3 Methods __________________________________________________________________________________ 9 2. Results ____________________________________________________________________________________ 10 2.1 Preparation of the list of optimised output indicators ______________________________ 10 2.2 List of output indicators _______________________________________________________________ 10 2.3 Link with Partnership Specific Impact Pathways (PSIPs) __________________________ 19 2.4 Link with CSS indicators ______________________________________________________________ 20 2.5 Reporting on output indicators _______________________________________________________ 20 2.6 Brief considerations on outcome and impact indicators ___________________________ 21 3. Conclusion and perspectives ____________________________________________________________ 21 4. References ________________________________________________________________________________ 22 5. Annexes ___________________________________________________________________________________ 23 7 8 9 16     17              18        19 Type of monitoring studies Number of participants Number of countries Number of substances Number of samples Environment Human Other (specify) 20 21 22 23 24 25 Objectives Outcome/ Impact Indi cato r No. What is a measure of success? General Objective (GO) 1: Consolidate and strengthen the EU's research and innovation capacity for chemical risk assessment to protect human health and the environment. Scientific Impact 1 INTERNATIONAL RECOGNITION of the scientific network for research & innovation in chemical risk assessment - worldclass science 2 Use of integrated exposure monitoring data for regulatory purposes 3 Contribution of PARC to achieving healthier working environments 4 Acceptance of methods, tools and models for use for regulatory purposes 5 By 2030, all chemical RA data in Europe is FAIR Policy and societal impact 6 Sustainable engagement of European chemical RA community at international level 7 Uptake of PARC outputs/results by policy makers/regulators at regional/national/EU/international level 8 Contribution of PARC to EU and international policy strategies (SDGs, Green Deal) 9 Workers, citizens and stakeholders' awareness about chemical risks and trust in science and how regulations protect humans and the environment. Economic Impact 10 Use of labo networks and infrastructural capacities by targeted end-users 11 Collaboration with industry to ensure use and further development of concepts and toolboxes developed in PARC 12 Participation of upskilled researchers in EU and international chemical RA networks 13 Composite indicator measuring different aspects such as: Number and degree of attendance of academic and competent authority training programmes in areas relevant to regulatory risk assessment triggered by the Partnership. (Survey amongst academic and regulatory partners) 32 69 Timely delivery of deliverables and milestones 33 34 35 36 37 38 39